Overcoming immune tolerance in chronic hepatitis B by therapeutic vaccination

Current Opinion in Virology
Claudia DembekMichael Roggendorf

Abstract

The currently used nucleoside analogs (i.e. entecavir and tenofovir) with high barrier-to-resistance efficiently suppress viral replication, limit inflammation and reduce the sequelae of chronic hepatitis B, but cannot cure the disease and thus have to be applied long-term. Therapeutic vaccination as an approach to cure chronic hepatitis B has shown promising pre-clinical results, nevertheless the proof of its efficacy in clinical trials is still missing. This may be partially due to suboptimal vaccine design. A main obstacle in chronic hepatitis B, however, is the high load of viral antigens expressed and secreted, which has been proposed to cause antigen-specific immune tolerance. Reduction of the viral antigen load is therefore considered a key factor for success of immune-based therapies. Although nucleoside analogs do not reduce viral antigen expression, new antiviral strategies are becoming available. Targeting viral translation by siRNA or targeting release of HBsAg from infected hepatocytes by nucleic acid polymers both reduce the antigen load. They may be considered as pre-treatment for therapeutic vaccination to increase the potential to elicit an HBV-specific immune response able to control and cure chronic HBV infec...Continue Reading

Citations

Feb 11, 2020·Frontiers in Cellular and Infection Microbiology·Shui-Zhen WuHong-Juan Peng
Jan 6, 2019·Virologica Sinica·Jianhao CaoYuanyan Xiong
Jun 15, 2019·International Journal of Molecular Sciences·Carolina BoniPaola Fisicaro
Sep 25, 2019·Nature Reviews. Gastroenterology & Hepatology·Mala K Maini, Alice R Burton
Aug 26, 2020·Expert Review of Clinical Pharmacology·Kimia KardaniAzam Bolhassani
Sep 19, 2020·Microorganisms·Magda Rybicka, Krzysztof Piotr Bielawski
Jan 3, 2019·Hepatology International·Julia LangRobert Thimme
Nov 29, 2020·Antiviral Research·Valeria BariliPaola Fisicaro
Nov 6, 2020·Infection and Drug Resistance·Maura Dandri, Joerg Petersen
Oct 28, 2018·Gastroenterology·Adam J Gehring, Ulrike Protzer
May 11, 2021·Clinical and Experimental Immunology·Tamsin Cargill, Eleanor Barnes

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.